Comparative effectiveness of spirapril and enalapril in patients with coronary heart disease-caused chronic heart failure

Comparative effectiveness of spirapril and enalapril in patients with coronary heart disease-caused chronic heart failure

Aim. During prospective 6-month follow-up, to compare spirapril and enalapril effectiveness in patients with coronary heart disease (CHD)-caused chronic heart failure (CHF). Material and methods. In total, 61 patients with CHD-caused CHF, according to inclusion/exclusion criteria, were divided into...

Full description

Saved in:

Bibliographic Details
Main Authors:	S, Yu. Volkova, V. V. Ragozina, V. A. Balina, M. A. Pushnikova, V. A. Shchupletsova, S. V. Shalaev
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2006-08-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	chronic heart failure ace inhibitor comparison spirapril enalapril nt-probnp
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1242
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Untargeted metabolic analysis in serum samples reveals metabolic signature in children with congenital heart failure on enalapril therapy
by: N. J. L. Smeets, et al.
Published: (2025-04-01)

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
by: M. M. Beraya, et al.
Published: (2007-02-01)

Relationships between the activity of neurohormonal systems and intracardiac hemodynamics in patients with heart failure: focus on galectin-3
by: V. I. Podzolkov, et al.
Published: (2022-05-01)

Cardiovascular disease and ACE inhibitors: focusing on enalapril
by: G. A. Baryshnikova
Published: (2007-12-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Level and correlations of soluble suppression of tumorigenicity 2 protein in heart failure and its relationship with clinical and paraclinical characteristics of patients
by: A. Ya. Kravchenko, et al.
Published: (2022-06-01)

Characteristics of patients with chronic heart failure in different age groups
by: R. I. Jafarov, et al.
Published: (2023-05-01)

Spirapril – a modern ACE inhibitor
by: V. M. Gorbunov
Published: (2005-06-01)

Effect of spironolactone on transmitral diastolic blood flow and course of chronic heart failure with preserved left ventricular ejection fraction
by: V. A. Vasylenko
Published: (2015-10-01)

Pharmacoepidemiological analysis of therapy for chronic heart failure
by: D. D. Monakhova, et al.
Published: (2023-09-01)

BIOMARKERS OF MYOCARDIAL STRESS AND FIBROSIS FOR CLINICAL OUTCOMES ASSESSMENT IN POST MYOCARDIAL INFARCTION HEART FAILURE PATIENTS
by: N V Shilyaeva, et al.
Published: (2018-03-01)

Importance of NT-pro BNP in the Prevention of Heart Failure, Left Ventricular Systolic Dysfunction and Cardiovascular Events
by: Irina CUCIUREANU, et al.
Published: (2021-06-01)

Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01)

Chronic Heart Failure in Early Rheumatoid Arthritis Patients Prior to Basic Antirheumatic Therapy
by: I. G. Kirillova, et al.
Published: (2020-03-01)

ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION
by: M. V. Leonova, et al.
Published: (2015-12-01)

Antihypertensive spirapril effectiveness in patients with mild to moderate arterial hypertension
by: M. M. Beraya, et al.
Published: (1970-01-01)

HEART FAILURE IN SYSTEMIC LUPUS ERYTHEMATOSUS: RISK FACTORS AND DIAGNOSTIC FEATURES
by: T. A. Panafidina, et al.
Published: (2018-07-01)

Clinical, pathogenetic, and diagnostic features of heart failure in patients with coronary heart disease and thyrotoxicosis
by: A. I. Chesnikova, et al.
Published: (2019-11-01)

Investigating the diagnostic accuracy of vertebral heart score, vertebral left atrium score and thoracic width measurement in cats with suspected cardiac problems
by: B. Ozdil, et al.
Published: (2025-03-01)

Spirapril effectiveness and organo-protection in patients with metabolic syndrome and arterial hypertension
by: V. E. Oleynikov, et al.
Published: (2007-08-01)

PARALLELS BETWEEN THE HEMODYNAMIC PROFILE AND BIOMARKERS ACTIVITY IN DIFFERENT FORMS OF ACUTE HEART FAILURE IN THE EARLY PERIOD AFTER AORTOCORONARY BYPASS
by: D. A. Laletin, et al.
Published: (2017-11-01)

Associations of NT-proBNP and hepcidin levels with clinical and laboratory parameters in patients with heart failure with various severity of left ventricular systolic dysfunction
by: V. I. Podzolkov, et al.
Published: (2020-09-01)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015-12-01)

Impact of obesity on echocardiographic parameters and N-terminal pro-brain natriuretic peptide levels in patients with heart failure with mid-range ejection fraction: unanswered questions
by: E. A. Lyasnikova, et al.
Published: (2021-07-01)

Diagnostic, prognostic and therapeutic potential of 6-minute walk test in patients with heart failure
by: A. V. Budnevsky, et al.
Published: (2020-12-01)

EFFECTS OF ENALAPRIL ON ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. I. Katelnizkaya, et al.
Published: (2016-01-01)

NT-proBNP for Heart Failure Screening in Primary Care in an Eastern European Country: What We Know and Proposed Steps
by: Ioana Camelia Teleanu, et al.
Published: (2025-01-01)

Comparative effectiveness of ACE inhibitors spirapril, fosinopril, and enalapril in complex therapy of patients with coronary heart disease, chronic obstructive pulmonary disease, and arterial hypertension
by: M. A. Popova, et al.
Published: (2006-06-01)

THE EFFECT OF ENALAPRIL ON THE FUNCTIONAL AND APOPTOTIC ACTIVITY OF NEUTROPHILS IN PATIENTS WITH RHEUMATIC HEART DISEASE
by: M. V. Ilyin, et al.
Published: (2015-12-01)

Renal venous Doppler ultrasound – a new parameter for predicting outcomes in patients with decompensated heart failure
by: Zh. D. Kobalava, et al.
Published: (2023-07-01)

Enalapril effects on renal function and ACE gene polymorphism in hypertensive nephropathy
by: K. Y. Zholdoshov, et al.
Published: (2010-10-01)

The effects of early exercise on cardiovascular biomarkers in patients with congestive heart failure
by: Yanxiang Sun, et al.
Published: (2025-08-01)

Plasma biomarkers for predicting heart failure in patients with acute myocardial infarction
by: Guihong Rong, et al.
Published: (2025-01-01)

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)

Comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesity
by: S. V. Nedogoda, et al.
Published: (1970-01-01)

Prevalence of heart failure among hospitalized patient with T2D: results of a prospective observational multicenter study (CREDO)
by: M. B. Antsiferov, et al.
Published: (2024-03-01)

Diagnostic value of cardiac marker concentrations in patients with heart failure depending on frailty syndrome
by: V. A. Safronenko, et al.
Published: (2024-10-01)

BRAIN NATRIURETIC PROPEPTIDE AS A MARKER OF THE HEART DAMAGE IN METABOLIC SYNDROME
by: R. A. Libis, et al.
Published: (2015-04-01)

Frailty determinants in heart failure: Inflammatory markers, cognitive impairment and psychosocial interaction
by: Marta Wleklik, et al.
Published: (2025-06-01)

Right heart condition in patients with COVID-19 pneumonia
by: N. G. Poteshkina, et al.
Published: (2021-12-01)